 Hanna Roberts
Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Factor VIIa | 19 | 2013 | 39 | 1.510 |
Why?
| | Thromboplastin | 20 | 2006 | 70 | 1.470 |
Why?
| | Factor IX | 27 | 2013 | 42 | 1.340 |
Why?
| | Blood Platelets | 15 | 2004 | 380 | 0.950 |
Why?
| | Blood Coagulation | 14 | 2004 | 238 | 0.920 |
Why?
| | Platelet Activation | 12 | 2004 | 91 | 0.790 |
Why?
| | Hemophilia B | 17 | 2013 | 48 | 0.650 |
Why?
| | Factor IXa | 15 | 2004 | 16 | 0.630 |
Why?
| | Factor Xa | 10 | 2000 | 32 | 0.600 |
Why?
| | Factor VII | 4 | 2004 | 22 | 0.570 |
Why?
| | Thrombin | 18 | 2007 | 146 | 0.570 |
Why?
| | Factor X | 17 | 2000 | 25 | 0.540 |
Why?
| | Recombinant Proteins | 9 | 2004 | 1304 | 0.440 |
Why?
| | Monocytes | 8 | 2004 | 551 | 0.390 |
Why?
| | Hemophilia A | 5 | 2007 | 115 | 0.320 |
Why?
| | Lipoproteins | 3 | 1999 | 171 | 0.290 |
Why?
| | Prothrombin Time | 6 | 1994 | 33 | 0.270 |
Why?
| | Epidermal Growth Factor | 3 | 1997 | 171 | 0.220 |
Why?
| | Amino Acid Chloromethyl Ketones | 3 | 1998 | 25 | 0.210 |
Why?
| | Factor XIa | 4 | 1998 | 4 | 0.210 |
Why?
| | Hemostasis | 3 | 2007 | 79 | 0.200 |
Why?
| | DNA, Complementary | 2 | 1999 | 270 | 0.180 |
Why?
| | Serine Proteinase Inhibitors | 2 | 1998 | 43 | 0.180 |
Why?
| | Blood Platelet Disorders | 1 | 2000 | 10 | 0.170 |
Why?
| | Biological Assay | 1 | 1998 | 118 | 0.150 |
Why?
| | Wound Healing | 2 | 2013 | 306 | 0.150 |
Why?
| | Calcium | 9 | 1999 | 1213 | 0.140 |
Why?
| | Cyclooxygenase Inhibitors | 1 | 1997 | 80 | 0.140 |
Why?
| | Platelet Aggregation | 1 | 1997 | 95 | 0.140 |
Why?
| | Cell Separation | 2 | 1995 | 316 | 0.120 |
Why?
| | Fibrinolytic Agents | 1 | 1997 | 263 | 0.120 |
Why?
| | Partial Thromboplastin Time | 2 | 1997 | 52 | 0.120 |
Why?
| | Cell Communication | 2 | 1996 | 301 | 0.120 |
Why?
| | Plasma | 2 | 2006 | 206 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 1 | 1997 | 643 | 0.110 |
Why?
| | Models, Biological | 3 | 2004 | 1722 | 0.110 |
Why?
| | Amino Acid Sequence | 11 | 1999 | 2058 | 0.110 |
Why?
| | Aspirin | 1 | 1997 | 380 | 0.110 |
Why?
| | Factor XI | 5 | 1999 | 9 | 0.110 |
Why?
| | Kinetics | 12 | 2006 | 1642 | 0.110 |
Why?
| | Humans | 56 | 2007 | 129650 | 0.110 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 1997 | 442 | 0.110 |
Why?
| | Coagulants | 1 | 2013 | 15 | 0.110 |
Why?
| | Purpura, Thrombotic Thrombocytopenic | 1 | 1993 | 12 | 0.100 |
Why?
| | Centrifugation, Density Gradient | 1 | 1992 | 39 | 0.100 |
Why?
| | Factor VIII | 5 | 1999 | 87 | 0.100 |
Why?
| | Blood Coagulation Factors | 3 | 2006 | 53 | 0.100 |
Why?
| | Genetic Variation | 5 | 1990 | 937 | 0.100 |
Why?
| | Blood Coagulation Tests | 4 | 1989 | 60 | 0.090 |
Why?
| | Benzamidines | 2 | 1988 | 3 | 0.090 |
Why?
| | Amidines | 2 | 1988 | 16 | 0.090 |
Why?
| | Protein Binding | 8 | 1998 | 2121 | 0.090 |
Why?
| | Trypsin | 2 | 1988 | 74 | 0.090 |
Why?
| | Cloning, Molecular | 4 | 1999 | 524 | 0.090 |
Why?
| | Base Sequence | 7 | 1999 | 2142 | 0.090 |
Why?
| | Antibodies | 5 | 1998 | 398 | 0.080 |
Why?
| | Cells, Cultured | 7 | 2006 | 4083 | 0.080 |
Why?
| | Sequence Analysis | 2 | 1999 | 37 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 1988 | 118 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2000 | 2012 | 0.070 |
Why?
| | Hemorrhage | 3 | 2007 | 678 | 0.070 |
Why?
| | Binding Sites | 5 | 1997 | 1252 | 0.070 |
Why?
| | Molecular Sequence Data | 5 | 1999 | 2832 | 0.070 |
Why?
| | Drug Administration Schedule | 3 | 2013 | 769 | 0.060 |
Why?
| | Animals | 17 | 2013 | 35361 | 0.060 |
Why?
| | Factor VIIIa | 2 | 1997 | 4 | 0.060 |
Why?
| | P-Selectin | 2 | 1997 | 27 | 0.060 |
Why?
| | Thrombocytopenia | 2 | 2001 | 186 | 0.060 |
Why?
| | Prothrombin | 3 | 1999 | 20 | 0.060 |
Why?
| | Cysteine Endopeptidases | 1 | 2004 | 68 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 2 | 1997 | 376 | 0.060 |
Why?
| | Hemarthrosis | 1 | 1984 | 20 | 0.050 |
Why?
| | Dogs | 3 | 1997 | 381 | 0.050 |
Why?
| | Structure-Activity Relationship | 7 | 1992 | 548 | 0.050 |
Why?
| | Cattle | 6 | 1993 | 976 | 0.050 |
Why?
| | Phosphatidylserines | 3 | 2000 | 88 | 0.050 |
Why?
| | DNA, Recombinant | 2 | 1997 | 46 | 0.050 |
Why?
| | Calcimycin | 3 | 2000 | 49 | 0.050 |
Why?
| | Membrane Proteins | 2 | 1998 | 1119 | 0.050 |
Why?
| | 1-Carboxyglutamic Acid | 3 | 1992 | 3 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2004 | 424 | 0.050 |
Why?
| | In Vitro Techniques | 4 | 1996 | 1085 | 0.040 |
Why?
| | Polylysine | 2 | 1990 | 17 | 0.040 |
Why?
| | Sequence Deletion | 1 | 2000 | 179 | 0.040 |
Why?
| | Mutation | 6 | 1994 | 3717 | 0.040 |
Why?
| | Factor XII | 2 | 1999 | 6 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2006 | 901 | 0.040 |
Why?
| | Factor VII Deficiency | 2 | 1994 | 4 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 2 | 1990 | 171 | 0.040 |
Why?
| | Flow Cytometry | 2 | 1992 | 1156 | 0.040 |
Why?
| | Mice | 5 | 2013 | 16937 | 0.040 |
Why?
| | Glutamates | 2 | 1990 | 56 | 0.040 |
Why?
| | Blood Coagulation Disorders | 1 | 1980 | 167 | 0.040 |
Why?
| | Dansyl Compounds | 1 | 1997 | 5 | 0.040 |
Why?
| | Binding, Competitive | 1 | 1997 | 206 | 0.030 |
Why?
| | Catalysis | 1 | 1998 | 310 | 0.030 |
Why?
| | Dog Diseases | 1 | 1997 | 52 | 0.030 |
Why?
| | Factor Va | 1 | 1996 | 2 | 0.030 |
Why?
| | Lipopolysaccharides | 2 | 1997 | 875 | 0.030 |
Why?
| | Liposomes | 2 | 1996 | 168 | 0.030 |
Why?
| | Hypoprothrombinemias | 2 | 1990 | 2 | 0.030 |
Why?
| | Factor X Deficiency | 2 | 1990 | 3 | 0.030 |
Why?
| | Drug Interactions | 1 | 1997 | 394 | 0.030 |
Why?
| | Factor Xa Inhibitors | 1 | 1997 | 170 | 0.030 |
Why?
| | Phosphatidylcholines | 1 | 1996 | 146 | 0.030 |
Why?
| | Arginine | 2 | 1989 | 265 | 0.030 |
Why?
| | Rabbits | 2 | 1993 | 778 | 0.030 |
Why?
| | Reference Values | 2 | 1993 | 793 | 0.030 |
Why?
| | Molecular Weight | 2 | 1989 | 332 | 0.030 |
Why?
| | Mice, Knockout | 2 | 2013 | 2871 | 0.030 |
Why?
| | Hematoma | 1 | 2013 | 54 | 0.030 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 1993 | 35 | 0.030 |
Why?
| | Electrophoresis | 1 | 1992 | 30 | 0.030 |
Why?
| | Blotting, Western | 1 | 1995 | 1205 | 0.030 |
Why?
| | Radioligand Assay | 1 | 1992 | 48 | 0.020 |
Why?
| | Protein Conformation | 3 | 1990 | 859 | 0.020 |
Why?
| | Time Factors | 3 | 1997 | 6556 | 0.020 |
Why?
| | Immunoglobulins | 1 | 1972 | 159 | 0.020 |
Why?
| | Iron | 1 | 2013 | 288 | 0.020 |
Why?
| | Anticoagulants | 3 | 1999 | 637 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2013 | 5440 | 0.020 |
Why?
| | Ionophores | 2 | 2000 | 22 | 0.020 |
Why?
| | Cinnamates | 2 | 1986 | 9 | 0.020 |
Why?
| | Benzoates | 2 | 1986 | 41 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 1999 | 2548 | 0.020 |
Why?
| | Enzyme Activation | 2 | 1988 | 811 | 0.020 |
Why?
| | Rats | 1 | 1998 | 5500 | 0.020 |
Why?
| | Glutamine | 1 | 1989 | 99 | 0.020 |
Why?
| | Skin | 2 | 2007 | 725 | 0.020 |
Why?
| | Adult | 4 | 1998 | 35576 | 0.020 |
Why?
| | Hydrolysis | 1 | 1988 | 186 | 0.020 |
Why?
| | Lysine | 1 | 1990 | 286 | 0.020 |
Why?
| | Phospholipids | 2 | 1985 | 215 | 0.020 |
Why?
| | Calcium Chloride | 1 | 2006 | 13 | 0.020 |
Why?
| | Neovascularization, Physiologic | 1 | 2007 | 176 | 0.020 |
Why?
| | Male | 8 | 1994 | 63681 | 0.020 |
Why?
| | Computer Simulation | 1 | 1990 | 943 | 0.020 |
Why?
| | Chemistry | 1 | 1985 | 44 | 0.020 |
Why?
| | Chemical Phenomena | 1 | 1985 | 81 | 0.020 |
Why?
| | Antithrombin III | 2 | 1999 | 8 | 0.020 |
Why?
| | Models, Molecular | 1 | 1990 | 1492 | 0.010 |
Why?
| | Signal Transduction | 1 | 1998 | 4925 | 0.010 |
Why?
| | Histidine | 1 | 1983 | 60 | 0.010 |
Why?
| | Cyclophosphamide | 1 | 1984 | 232 | 0.010 |
Why?
| | Aorta | 1 | 2006 | 411 | 0.010 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2006 | 443 | 0.010 |
Why?
| | Whole Blood Coagulation Time | 1 | 1981 | 2 | 0.010 |
Why?
| | Peptide Chain Termination, Translational | 1 | 1981 | 5 | 0.010 |
Why?
| | Biotransformation | 1 | 1981 | 66 | 0.010 |
Why?
| | Neutralization Tests | 2 | 1972 | 73 | 0.010 |
Why?
| | Platelet Count | 1 | 2001 | 82 | 0.010 |
Why?
| | Swine | 1 | 1984 | 760 | 0.010 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1981 | 330 | 0.010 |
Why?
| | Factor V | 2 | 1999 | 18 | 0.010 |
Why?
| | Annexin A5 | 1 | 2000 | 23 | 0.010 |
Why?
| | Oligonucleotide Probes | 2 | 1990 | 50 | 0.010 |
Why?
| | Immunoelectrophoresis, Two-Dimensional | 1 | 1980 | 1 | 0.010 |
Why?
| | Cell Size | 1 | 2000 | 89 | 0.010 |
Why?
| | Female | 4 | 1993 | 68776 | 0.010 |
Why?
| | Cricetinae | 1 | 2000 | 277 | 0.010 |
Why?
| | Membrane Lipids | 1 | 2000 | 91 | 0.010 |
Why?
| | Kininogens | 1 | 1999 | 6 | 0.010 |
Why?
| | Oxidation-Reduction | 1 | 1981 | 1033 | 0.010 |
Why?
| | Transfection | 1 | 2000 | 911 | 0.010 |
Why?
| | Joints | 1 | 1998 | 100 | 0.010 |
Why?
| | Protein Structure, Tertiary | 1 | 2000 | 840 | 0.010 |
Why?
| | Injections, Intraperitoneal | 1 | 1997 | 111 | 0.010 |
Why?
| | Metabolic Clearance Rate | 1 | 1997 | 118 | 0.010 |
Why?
| | Half-Life | 1 | 1997 | 162 | 0.010 |
Why?
| | Biological Availability | 1 | 1997 | 147 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 1997 | 201 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1997 | 116 | 0.010 |
Why?
| | North Carolina | 1 | 1977 | 99 | 0.010 |
Why?
| | Cell Membrane | 1 | 2000 | 732 | 0.010 |
Why?
| | Species Specificity | 2 | 1990 | 575 | 0.010 |
Why?
| | Cell Line | 1 | 2000 | 2781 | 0.010 |
Why?
| | Fibroblasts | 1 | 1999 | 948 | 0.010 |
Why?
| | Double-Blind Method | 1 | 1998 | 1876 | 0.010 |
Why?
| | Immunodiffusion | 1 | 1972 | 15 | 0.010 |
Why?
| | Blood Protein Electrophoresis | 1 | 1972 | 8 | 0.010 |
Why?
| | Immunochemistry | 1 | 1972 | 13 | 0.010 |
Why?
| | Goats | 1 | 1972 | 26 | 0.010 |
Why?
| | Immune Sera | 1 | 1972 | 86 | 0.010 |
Why?
| | Macaca | 1 | 1972 | 54 | 0.010 |
Why?
| | Papio | 1 | 1972 | 91 | 0.010 |
Why?
| | Antibody Specificity | 1 | 1972 | 184 | 0.010 |
Why?
| | RNA, Messenger | 1 | 1999 | 2708 | 0.010 |
Why?
| | Dialysis | 1 | 1990 | 18 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1970 | 76 | 0.010 |
Why?
| | Sex Chromosomes | 1 | 1970 | 50 | 0.010 |
Why?
| | Immune Tolerance | 1 | 1972 | 355 | 0.010 |
Why?
| | Cross Reactions | 1 | 1990 | 132 | 0.010 |
Why?
| | Genetic Carrier Screening | 1 | 1989 | 26 | 0.000 |
Why?
| | Pedigree | 1 | 1990 | 487 | 0.000 |
Why?
| | Chromosome Mapping | 1 | 1970 | 504 | 0.000 |
Why?
| | Exons | 1 | 1990 | 342 | 0.000 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1989 | 69 | 0.000 |
Why?
| | Muscle, Skeletal | 1 | 1998 | 1614 | 0.000 |
Why?
| | Ligands | 1 | 1990 | 622 | 0.000 |
Why?
| | Gene Amplification | 1 | 1989 | 105 | 0.000 |
Why?
| | Glutamic Acid | 1 | 1990 | 237 | 0.000 |
Why?
| | Protein Processing, Post-Translational | 1 | 1990 | 455 | 0.000 |
Why?
| | Immunoglobulin G | 1 | 1972 | 847 | 0.000 |
Why?
| | Polymerase Chain Reaction | 1 | 1990 | 1038 | 0.000 |
Why?
| | Antithrombins | 1 | 1967 | 58 | 0.000 |
Why?
| | Acylation | 1 | 1986 | 28 | 0.000 |
Why?
| | Lysosomes | 1 | 1967 | 138 | 0.000 |
Why?
| | Indicators and Reagents | 1 | 1986 | 109 | 0.000 |
Why?
| | Infant | 1 | 1980 | 9024 | 0.000 |
Why?
| | Benzoic Acid | 1 | 1986 | 4 | 0.000 |
Why?
| | Leukocytes | 1 | 1967 | 304 | 0.000 |
Why?
| | Cations, Divalent | 1 | 1985 | 56 | 0.000 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1986 | 539 | 0.000 |
Why?
| | Treatment Outcome | 1 | 1998 | 10230 | 0.000 |
Why?
| | Proteins | 1 | 1967 | 942 | 0.000 |
Why?
| | Brain | 1 | 1970 | 2679 | 0.000 |
Why?
| | Cellulose | 1 | 1965 | 61 | 0.000 |
Why?
|
|
Roberts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|